About Adaptive Biotechnologies

What does Adaptive Biotechnologies do?

Adaptive Biotechnologies is a provider of immune system-based products to diagnose and treat disease, including clonoSEQ, an FDA-cleared service for detecting and monitoring minimal residual disease in bone marrow from patients with certain blood cancers; immunoSEQ, a tool for profiling and monitoring the adaptive immune response, aiding research across multiple disease areas; and T-Detect COVID, a diagnostic using T cell markers, authorized for emergency use.

Who are Adaptive Biotechnologies's competitors?

Adaptive Biotechnologies's competitors and similar companies include VisionGate, Century Therapeutics, Forty Seven, Immago, and NovelStem.

Where is Adaptive Biotechnologies headquartered?

Adaptive Biotechnologies is headquartered in United States.

How many employees does Adaptive Biotechnologies have?

Adaptive Biotechnologies has 1,000 employees 🔒.

When was Adaptive Biotechnologies founded?

Adaptive Biotechnologies was founded in 2010 🔒.

What sector and industry vertical is Adaptive Biotechnologies in?

Adaptive Biotechnologies is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adaptive Biotechnologies

Who are the top strategic acquirers in Adaptive Biotechnologies's sector and industry

Top strategic M&A buyers and acquirers in Adaptive Biotechnologies's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adaptive Biotechnologies?

Top strategic M&A buyers groups and sectors for Adaptive Biotechnologies include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adaptive Biotechnologies's sector and industry vertical

Which are the top PE firms investing in Adaptive Biotechnologies's sector and industry vertical?

Top PE firms investing in Adaptive Biotechnologies's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adaptive Biotechnologies's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adaptive Biotechnologies's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adaptive Biotechnologies's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adaptive Biotechnologies include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adaptive Biotechnologies's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adaptive Biotechnologies?

The key public trading comparables and valuation benchmarks for Adaptive Biotechnologies include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adaptive Biotechnologies for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adaptive Biotechnologies with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adaptive Biotechnologies's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adaptive Biotechnologies with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adaptive Biotechnologies's' sector and industry vertical?

Access recent funding rounds and capital raises in Adaptive Biotechnologies's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.